Source:http://linkedlifedata.com/resource/pubmed/id/14970208
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
2004-4-26
|
pubmed:abstractText |
Dermal fibroblasts derived from types I and IV Ehlers-Danlos syndrome (EDS) patients, carrying mutations in COL5A1 and COL3A1 genes, respectively, synthesize aberrant types V and III collagen (COLL) and show defective organization of these proteins into the extracellular matrix (ECM) and high reduction of their functional receptor, the alpha(2)beta(1) integrin, compared with control fibroblasts. EDS cells also show reduced levels of fibronectin (FN) in the culture medium and lack an FN fibrillar network. Finally, EDS cells prevalently organize alpha(v)beta(3) integrin instead of alpha(5)beta(1) integrin. The alpha(v)beta(3) integrin, distributed on the whole EDS cell surface, shows FN binding and assembly properties when the cells are treated with purified FN. Treatment of EDS cells with purified COLLV or COLLIII, but not with FN, restores the control phenotype (COLL(+), FN(+), alpha(v)beta(3)(-), alpha(5)beta(1)(+), alpha(2)beta(1)(+)). Function-blocking antibodies to COLLV, COLLIII, or alpha(2)beta(1) integrin induce in control fibroblasts an EDS-like phenotype (COLL(-), FN(-), alpha(v)beta(3)(+), alpha(5)beta(1)(-), alpha(2)beta(1)(-)). These results show that in human fibroblasts alpha(2)beta(1) integrin organization and function are controlled by its ligand, and that the alpha(2)beta(1)-COLL interaction, in turn, regulates FN integrin receptor recruitment: high alpha(2)beta(1) integrin levels induce alpha(5)beta(1) integrin organization, while low alpha(2)beta(1) integrin levels lead to alpha(v)beta(3) integrin organization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/COL3A1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type III,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type V,
http://linkedlifedata.com/resource/pubmed/chemical/Fibronectins,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alpha2beta1,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alpha5beta1,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alphaVbeta3,
http://linkedlifedata.com/resource/pubmed/chemical/Integrins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
279
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
18157-68
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14970208-Adolescent,
pubmed-meshheading:14970208-Cells, Cultured,
pubmed-meshheading:14970208-Collagen,
pubmed-meshheading:14970208-Collagen Type III,
pubmed-meshheading:14970208-Collagen Type V,
pubmed-meshheading:14970208-Down-Regulation,
pubmed-meshheading:14970208-Ehlers-Danlos Syndrome,
pubmed-meshheading:14970208-Extracellular Matrix,
pubmed-meshheading:14970208-Fibroblasts,
pubmed-meshheading:14970208-Fibronectins,
pubmed-meshheading:14970208-Humans,
pubmed-meshheading:14970208-Integrin alpha2beta1,
pubmed-meshheading:14970208-Integrin alpha5beta1,
pubmed-meshheading:14970208-Integrin alphaVbeta3,
pubmed-meshheading:14970208-Integrins,
pubmed-meshheading:14970208-Mutation
|
pubmed:year |
2004
|
pubmed:articleTitle |
Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate alpha2beta1 integrin, and recruit alphavbeta3 Instead of alpha5beta1 integrin.
|
pubmed:affiliation |
Division of Biology and Genetics, Department of Biomedical Sciences and Biotechnology, Medical Faculty, University of Brescia, 25123 Brescia, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|